Engage Bio

YC W22 · Acquired · Potent, durable, and redosable non-viral genetic medicines

Competitors

Companies closest to Engage Bio
Company	Category	Status	Program
Serna BioShared: genetic medicine, drug discovery, biotechActiveOther	Other	Active	YCW21
ParcelBioShared: synthetic biology, drug discovery, therapeuticsActiveOther	Other	Active	YCW24
NanograbShared: non viral, genetic medicine, therapeuticsActiveAI	AI	Active	YCS23
Granza BioShared: synthetic biology, therapeutics, biotechActiveOther	Other	Active	YCW24
Nuntius TherapeuticsShared: genetic medicine, therapeuticsActiveOther	Other	Active	YCW21

Adjacent

Companies next to Engage Bio
Company	Category	Status	Program
Velorum TherapeuticsShared: drug discovery, therapeutics, biotechActiveOther	Other	Active	YCW24
NephrogenShared: genetic medicine, biotech, therapeuticsActiveAI	AI	Active	YCS20
Sensible BiotechnologiesShared: synthetic biology, therapeutics, biotechActiveOther	Other	Active	YCS21
SynsoryBioShared: synthetic biology, therapeutics, biotechActiveOther	Other	Active	YCW24
Eris BiotechShared: drug discovery, therapeutics, biotechActiveOther	Other	Active	YCW24

Also from W22

All of W22

Company	Category	Status
InvertData analytics software for biomanufacturing.ActiveAI	AI	Active
ArintraEnterprise-grade AI for revenue assuranceActiveAI	AI	Active
BemloAI-native scheduling and workforce management platform for healthcareActiveAI	AI	Active
Brown FoodsMaking 'REAL' Cow and Human Milk!ActiveAI	AI	Active
FlowDeployBioinformatics pipelines in the cloudInactiveData, Devtools	Data, Devtools	Inactive
HypaHubA Cloud-Based Bioinformatics and AI PlatformAcquiredAI, Data	AI, Data	Acquired

About Engage Bio

Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.

YC batch: W22 · Winter 2022
Status, per YC: Acquired
Category: Other
Team size: 10
Location: San Francisco, CA, USA
Checked: 1h ago

YC tags: Synthetic Biology, Biotech, Healthcare, Therapeutics, Drug discovery

Engage Bio in W22: 398 companies, 44% AI

Engage Bio: questions

Which YC batch was Engage Bio in?

Engage Bio was in Y Combinator's Winter 2022 batch (W22).

Is Engage Bio still active?

Y Combinator lists Engage Bio as acquired.

Where is Engage Bio based?

Engage Bio lists San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.